Melasma treatment: oral tranexamic acid plus microneedling
Treatments studied
Part of Skin clinical trials.
This study tests whether combining oral tranexamic acid with a special skin needling treatment helps reduce melasma (dark facial patches). It is designed for women aged 18-50 who have melasma and are not pregnant or on certain medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 50 years old.
- You have dark patches on your face called melasma.
- You are not pregnant or breastfeeding.
- You do not have any bleeding or clotting disorders, and you do not take blood thinners.
- You have not used the acne medication isotretinoin in the last 6 months.
- You do not take birth control pills or hormone replacement therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This study tests whether adding an oral medication (tranexamic acid) to a standard triple cream for melasma works better than the cream alone. It may help if you have medium-to-severe melasma and are generally healthy.
This trial tests whether a cream containing metformin or tranexamic acid can reduce melasma (dark patches on the face). It aims to see which treatment works better.
This trial compares two treatments for melasma, a common skin condition causing dark patches on the face. One treatment uses an injection into the affected skin (tranexamic acid), while the other uses a chemical peel (mandelic acid). The study aims to see which works better and is safer for people with darker skin tones.
This trial compares two topical creams—tranexamic acid and ethyl ascorbic acid (a form of vitamin C)—to see which works better for melasma, a common skin condition that causes dark patches on the face. The study will help determine which treatment is more effective.
This trial tests a new gel containing three active ingredients to treat melasma, a condition that causes dark patches on the skin, usually on the face. The gel is applied to the skin and may help reduce discoloration and improve skin appearance.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.